Low Doses of Bevacizumab Tested for Retinopathy of Prematurity

FRIDAY, April 24, 2020 -- For treatment of retinopathy of prematurity (ROP), 0.004 mg may be the lowest effective dose of bevacizumab, according to a study published online April 23 in JAMA Ophthalmology. David K. Wallace, M.D., from the Jaeb Center...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news